These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15312537)

  • 21. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.
    Ortiz M; Jacas C; Córdoba J
    J Hepatol; 2005; 42 Suppl(1):S45-53. PubMed ID: 15777572
    [No Abstract]   [Full Text] [Related]  

  • 22. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.
    Montagnese S; Middleton B; Skene DJ; Morgan MY
    Liver Int; 2009 Oct; 29(9):1372-82. PubMed ID: 19686311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute of Medical Sciences Islamabad.
    Maqsood S; Saleem A; Iqbal A; Butt JA
    J Ayub Med Coll Abbottabad; 2006; 18(4):58-62. PubMed ID: 17591012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey.
    Bajaj JS; Etemadian A; Hafeezullah M; Saeian K
    Hepatology; 2007 Mar; 45(3):833-4. PubMed ID: 17326210
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic methods in hepatic encephalopathy.
    Quero Guillén JC; Herrerías Gutiérrez JM
    Clin Chim Acta; 2006 Mar; 365(1-2):1-8. PubMed ID: 16168979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
    Mullen KD
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():11-6. PubMed ID: 17295847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy.
    Romero-Gómez M
    J Hepatol; 2007 Jul; 47(1):10-1. PubMed ID: 17507110
    [No Abstract]   [Full Text] [Related]  

  • 28. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.
    Sugimoto R; Iwasa M; Maeda M; Urawa N; Tanaka H; Fujita N; Kobayashi Y; Takeda K; Kaito M; Takei Y
    Am J Gastroenterol; 2008 Jun; 103(6):1413-20. PubMed ID: 18510613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
    Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical flicker test: yet another tool for minimal hepatic encephalopathy.
    Varghese J; Thiravia MA; Natarajan B; Venkataraman J
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):1031. PubMed ID: 18049178
    [No Abstract]   [Full Text] [Related]  

  • 33. [The latest consensus for hepatic encephalopathy].
    Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):261-4. PubMed ID: 12773234
    [No Abstract]   [Full Text] [Related]  

  • 34. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough.
    Amodio P; Valenti P; Del Piccolo F; Pellegrini A; Schiff S; Angeli P; Poci C; Mapelli D; Iannizzi P; Gatta A
    Dig Liver Dis; 2005 Nov; 37(11):861-8. PubMed ID: 16183341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal hepatic encephalopathy. Should we treat it?
    Toapanta-Yanchapaxi L; López-Velázquez JA; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2013; 12(3):487-92. PubMed ID: 23619267
    [No Abstract]   [Full Text] [Related]  

  • 36. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL).
    Vincent KA; Carr AJ; Walburn J; Scott DL; Rose MR
    Neurology; 2007 Mar; 68(13):1051-7. PubMed ID: 17389311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.
    Randolph C; Hilsabeck R; Kato A; Kharbanda P; Li YY; Mapelli D; Ravdin LD; Romero-Gomez M; Stracciari A; Weissenborn K;
    Liver Int; 2009 May; 29(5):629-35. PubMed ID: 19302444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
    Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
    Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a clinical hepatic encephalopathy staging scale.
    Ortiz M; Córdoba J; Doval E; Jacas C; Pujadas F; Esteban R; Guardia J
    Aliment Pharmacol Ther; 2007 Sep; 26(6):859-67. PubMed ID: 17767470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.